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Abstract
Background: Morbidity and mortality due to pregnancy and childbearing are high in developing countries. This
study aims to estimate patient and health system costs of managing pregnancy and birth-related complications in
sub-Saharan Africa.
Methods: A systematic review of the literature was conducted to identify costing studies published and
unpublished, from January 2000 to May 2019. The search was done in Pubmed, EMBASE, Cinahl, and Web of
Science databases and grey literature. The study was registered in PROSPERO with registration No.
CRD42019119316. All costs were converted to 2018 US dollars using relevant Consumer Price Indices.
Results: Out of 1652 studies identified, 48 fulfilled the inclusion criteria. The included studies were of moderate to
high quality. Spontaneous vaginal delivery cost patients and health systems between USD 6–52 and USD 8–73, but
cesarean section costs between USD 56–377 and USD 80–562, respectively. Patient and health system costs of
abortion range between USD 11–66 and USD 40–298, while post-abortion care costs between USD 21–158 and
USD 46–151, respectively. The patient and health system costs for managing a case of eclampsia range between
USD 52–231 and USD 123–186, while for maternal hemorrhage they range between USD 65–196 and USD 30–127,
respectively. Patient cost for caring low-birth weight babies ranges between USD 38–489 while the health system
cost was estimated to be USD 514.
Conclusion: This is the first systematic review to compile comprehensive up-to-date patient and health system
costs of managing pregnancy and birth-related complications in sub-Saharan Africa. It indicates that these costs are
relatively high in this region and that patient costs were largely catastrophic relative to a 10 % of average national
per capita income.
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Introduction
An estimated 303,000 preventable deaths occurred during
pregnancy and childbirth globally in 2015, mostly as a re-
sult of pregnancy and birth-related complications. Most of
these maternal deaths occurred in low-income countries,
particularly in sub-Saharan Africa. About three-quarters
of these complications include unsafe abortions, hyperten-
sive disorders in pregnancy i.e. pre-eclampsia and eclamp-
sia, sepsis, severe bleeding, and complications arising at
the time of delivery [1, 2]. Globally, about 17 million girls
aged less than 19 years give births every year, and about 4
million undergo unsafe abortions to terminate unwanted
pregnancies, and these adolescent pregnancies are associ-
ated with elevated risks of complications [1–3]. Pregnancy
and childbearing complications are ranked fourth globally
and second in low- and middle-income countries among
the leading causes of death in adolescent girls [4].
The United Nations Development Fund reports that
the prevalence of adolescent pregnancy has decreased
globally, but remained relatively unchanged in sub-
Saharan Africa [5]. By 2030, it is expected that the popu-
lation of adolescent girls in sub-Saharan Africa will grow
by 50%; hence, escalating the problem of teen pregnancy
and childbearing [5]. Since adolescent pregnancy is asso-
ciated with elevated risk of complications [1–3], it is
likely that the total costs of treating pregnancy and
childbearing complications in sub-Saharan Africa will
also increase. The cost of pregnancy and birth-related
complications have been synthesized and documented in
systematic reviews conducted elsewhere [6–8] but not in
sub-Saharan Africa despite being the region that carries
the largest burden of maternal death globally [5].
This study aims to assess patient and health system
costs associated with the management of pregnancy and
birth-related complications in sub-Saharan Africa. The
results will feed into a cost-benefit analysis study com-
paring two adolescent pregnancy prevention strategies in
Zambia to help policymakers to choose the strategy with
the greatest potential for return on investment [9]. The
study findings may also be useful to researchers and
policymakers elsewhere as it aims to provide cost evi-
dence that can facilitate economic evaluation and budget
impact analyses of maternal and child health interven-
tions to demonstrate whether they represent value for
money or not in addition to positive public health
impact.
Methods
We used the PRISMA checklist that is recommended for
reporting a systematic review and meta-analysis of clin-
ical trials [10], with slight modifications to suit the re-
view of costing studies. The study protocol was
registered with PROSPERO-the International Prospect-
ive Register of Systematic Reviews with registration No.
CRD42019119316.
Search strategy and inclusion criteria
The search of the literature was conducted by ATM in
Pubmed, EMBASE, Cinahl, and Web of Science data-
bases using combinations of the following search terms:
cost, costs, cost of illness, economic burden, cost ana-
lysis, healthcare costs, health care costs, preterm birth,
low birth weight, preeclampsia, eclampsia, abortion,
post-abortion complication, cesarean section, and indi-
vidual names of sub-Saharan African countries. An ex-
ample of a search code used to search in Pubmed is
shown in Table 1. The last search of these databases was
conducted on 26th November 2018. However, we
allowed Pubmed and Web of Science to send us weekly
updates on the saved search terms until 13th May 2019,
during which two more qualifying articles were found.
Other articles were identified by scanning reference lists
of review papers and relevant costing studies and search-
ing with the Google search engine using the above-
mentioned search terms. We also contacted some au-
thors to ask for unpublished articles.
We included costing studies that i) were conducted in
sub-Saharan Africa ii) published from January 2000 to
13th May 2019 iii) targeted normal delivery as well as
pregnancy and birth-related complications including
Table 1 Search in PubMed
No. Search query
#1 (cost) OR “economic cost”) OR “economic analysis”) OR “economic burden”) OR “healthcare cost”) OR “cost of illness”) OR “health care cost”)
OR “patient cost”))
#2 (eclampsia) OR preeclampsia) OR pre-eclampsia) OR “pre eclampsia”) OR “preterm birth”) OR “pre-term birth”) OR premature) OR “low birth
weight”) OR low-birth weight) OR “lowbirth weight”) OR “small for gestational age”) OR still-birth) OR stillbirth) OR abortion) OR “post
abortion complication”) OR c-section) OR “cesarean section”))
#3 (Angola) OR Benin) OR Botswana) OR Burkina Faso) OR Burundi) OR Cameroon) OR Cape Verde) OR Central African Republic) OR Chad) OR
Comoros) OR Congo) OR Cote d’Ivoire) OR Djibouti) OR Equatorial Guinea) OR Eritrea) OR Gabon) OR Ethiopia) OR The Gambia) OR Ghana)
OR Guinea) OR Guinea-Bissau) OR Kenya) OR Lesotho) OR Liberia) OR Malawi) OR Madagascar) OR Mali) OR Mauritania) OR Mauritius) OR
Mozambique) OR Namibia) OR Niger) OR Nigeria) OR Rwanda) OR Reunion) OR (Sao Tome and Principles)) OR Senegal) OR Seychelles) OR
Sudan) OR Sierra Leone) OR Somalia) OR South Africa) OR Swaziland) OR Tanzania) OR Togo) OR Uganda) OR Western Sahara) OR Zambia)
OR Zimbabwe)
#4 #1 AND #2 AND #3
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pre-eclampsia, eclampsia, pre-term birth, low birth
weight babies, small for gestational age babies, unsafe
abortion and post-abortion complications. The search
was limited to humans and the English language. Review
papers and reports were excluded because we were only
interested in primary cost data, but they were instead
used to identify other relevant studies. Two reviewers
(ATM and PB) independently screened the titles and ab-
stracts of all the articles to assess eligibility and the
qualifying ones were subjected to further screening for
eligibility by the two reviewers by reading the full text.
Quality assessment
Quality assessment was conducted independently by
ATM and PH. To the best of our knowledge, there is no
quality assessment guideline for cost studies: hence, we
developed an 8-item checklist from Drummond et al.
[11], Liers et al. [12], and the Consolidated Health Eco-
nomic Evaluation Reporting Standards (CHEERS) [13].
The 8 items were: i) description of the characteristics of
the study population and the reasons why it was chosen;
ii) the costing methodology used must be clearly re-
ported, whether micro-costing or gross costing approach
or a combination; iii) the sources used to collect re-
source utilization data should be reported clearly (e.g.
clinical trials, administrative databases, clinical databases,
medical records and published literature); iv) resource
quantities should be reported or described independ-
ently from the costs, so that assessment of the measure-
ment method is facilitated; v) the viewpoint/ perspective
of the analysis such as the provider, patient and family
or societal perspectives should be clearly described;vi) all
costs should be adjusted to a specific price year so that
the effects of inflation are removed from the cost estima-
tion; vii) If the time horizon for estimating costs was
longer than 1 year, discounting should have been per-
formed to reflect time preferences viii) if prices were
used instead of costs, they should reflect the true oppor-
tunity costs. Quality was assessed by scoring each of the
items with a value of 1 if fully completed, 0.5 if not fully
completed, 0 if not completed, and NA if not applicable.
The quality scores were categorized as ‘low’ if ≤33%,
‘moderate’ if the score was between 33 and 66%, and
‘high’ if > 66%. Disagreements on eligibility or the quality
assessments were resolved through consensus.
Data analysis
We extracted information about the name of the pri-
mary author, year of publication, year in which the data
was collected, study design, the country in which data
was collected, costing perspective used, the currency
used, cost information, disease condition, target popula-
tion from which data was collected and the level of the
healthcare facility.
Costs were categorized as health system costs if they
were borne by the healthcare facility and patient costs if
they were borne by the patient or caregiver. Health sys-
tem costs could further be categorized as recurrent if
spent on items that are used up in the course of the year
such as salaries, supplies, and utilities or capital costs if
spent on items that last more than a year such as build-
ings, furniture, and equipment. Patient costs included
both direct costs and indirect costs. Direct costs were
those paid in the process of seeking/accessing care and
included out-of-pocket payment for treatment (registra-
tion, diagnosis, radiology, drugs, bed days, etc), transport
to and from the healthcare facility, food, and other re-
lated expenses. Indirect costs were those that resulted
from the loss of income as a result of not being able to
engage in economically productive activities due to ill-
ness. When costs were reported separately for public,
private, or non-governmental organizations, etc., we
computed a simple average.
Base year costs in local currencies were first converted
to US dollars (USD) using the existing exchange rate for
the base years of the individual studies, before adjust-
ment to 2018 USD using relevant US Consumer Price
Indices (CPI) [14]. Annual Gross National Income (GNI)
per capita was used as a proxy of household income and
out of pocket patient payments that exceeded 10% of
this income were assumed to constitute catastrophic
health expenditure [15].
Results
In total 1652 studies were identified from the systematic lit-
erature search, of which 373 studies were duplicates. The
remaining 1279 unique studies were subjected to first stage
screening for eligibility by reading the titles and abstracts,
and as a result, 1201 studies were excluded because they
were not relevant, and 6 articles were not available as full
texts. The full-text screening was done for the remaining
72 articles, of which 48 were included (Fig. 1).
Table 2 shows the summary characteristics of the in-
cluded studies. Most of the studies used cross-sectional
design and data were collected at households and health-
care facilities depending on the chosen costing perspec-
tive. Out of the 48 studies, 36 were relatively recent and
were published in the year 2010 or after. All studies were
of moderate to high quality and provided a good de-
scription of the study population and the reason for its
selection and the sources used to collect information
about resource use. Only a few studies were explicit
about the costing methodology used, but the majority
provided descriptions of the perspective used.
Figure 2 shows the distribution of the studies in the
sub-Saharan African region. The majority were from
West and East Africa, while a few were from Southern
Africa.
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Table 3 shows the unit costs for normal delivery and
C-section services. There were 19 studies from 27 coun-
tries that reported the costs of normal delivery and 20
studies from 24 countries that reported the costs of C-
section. Patient cost (n = 13) for normal delivery range
from USD 5.6–52.4 and the health system cost (n = 6)
range from USD 8.4–72.8. However, only five of the
thirteen studies reported both direct and indirect patient
costs and four of the six studies reported both recurrent
and capital health system costs. The patient cost (n = 11)
for C-section ranges from USD 55.8–377.3 but only
three of the eleven studies reported both direct and in-
direct patient costs. The health system cost (n = 9) for
C-section ranges from USD 79.7–561.8 but only seven
of the nine studies reported both recurrent and capital
health system costs.
Table 4 shows the unit costs for abortion and post-
abortion care services (PAC). There were 9 studies from
8 countries that reported the costs of abortion and 4 that
reported the costs of PAC. Cost of abortion care
represented mostly the medical abortion, while costs of
PAC represented unsafe abortions (complete or incom-
plete), often performed outside the hospital setting with
the woman ending up in hospital as a result of complica-
tions. Patient cost (n = 8) and health system costs for
abortion care services (n = 4) range from USD 11.2–65.7
and USD 40.3–298.3, respectively. Only two of the eight
studies reported direct and indirect patient costs while
three of the four studies reported both recurrent and
capital health system costs. For PAC services the re-
ported patient cost (n = 6) ranges from USD 20.8–158.4
and all studies reported direct costs only. The health sys-
tem costs for PAC (n = 8) were in the range between
USD 46.1–151.1, and three of the eight studies reported
both recurrent and capital costs.
Table 5 shows the unit costs for the management of
eclampsia, low birth weight, and hemorrhage. There
were 17 unique studies conducted in 22 countries. For
the management of eclampsia, patient costs (n = 5) range
between USD 51.6–230.5, and two of the five studies
Fig. 1 Flow diagram showing articles included and excluded in the systematic review
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Table 2 Study characteristics









Akalu et al. (2012) [17] Ethiopia Largely rural Cross-sectional
household survey
Women (15–49 years) who
have used reproductive
health services in the past
12 months
2007–2008 High





Asante et al. (2007) [19] Ghana Unspecified Facility survey Women who had vaginal
deliveries at health facilities,
at homes and those who
had C-sections
2004–2005 High





Borghi et al. (2003) [21] Benin Unspecified Cross-sectional
hospital-based
Women with spontaneous






vaginal delivery and near-
miss obstetric complications
1999–2000 High





Carnelissen et al. (2017) [23] Malawi Unspecified Cross-sectional
hospital-based
Patients including women
requiring a surgical procedure
2014–2015 High















Deboutte et al. (2015) [27] DR Congo Urban and Rural Case-Control Women with Caesarean section









and preterm/low birth weight
2016 High
Henshaw et al. (2008) [29] Nigeria Urban &Rural Cross-sectional
hospital-based
Women admitted to hospital
for complications of induced
or spontaneous abortion or to
obtain an abortion
2002–2003 Moderate
Honda et al. (2011) [30] Madagascar Mainly urban Cross-sectional
hospital-based
Women having C-sections and
children admitted for neonatal
care
2007–2008 High
Ilboudo et al. (2015) [31] Burkina Faso Urban Cross-sectional
hospital-based
Women with induced or
spontaneous abortions
2012 High
Ilboudo et al. (2016) [32] Burkina Faso Urban Cross-sectional
hospital-based
Women with induced abortion
complications
2010 High
Johns et al. (2019) [33] Uganda
Zambia
Unspecified Retrospective Women attending health
facilities for maternal and
newborn healthcare services
2017–2018 High
Kalu-Umeh et al. (2013) [34] Nigeria Semi-rural Cross-sectional
community based
Women within the reproductive
age group who had experienced





Tanzania Urban and Rural Cross-sectional
hospital-based
Women receiving antenatal and
maternal healthcare services
1997–1998 High
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Table 2 Study characteristics (Continued)




Kruk et al. (2008) [36] Tanzania Rural Retrospective Women who delivered in
health facilities within the
previous 5 year
2007 Moderate


































Lofgren et al. (2015) [43] Uganda Rural/Semi-
urban
Prospective observational Patients including women
requiring a surgical procedure
2011 High




Women who had delivered
or received emergency
obstetric care at public
health facilities
2016 High




Women treated for unsafe
abortion complications
2016 High
Moore et al. (2018) [46] Zambia Urban Cross-sectional
hospital-based
Women receiving safe and
unsafe abortions
2014–2015 Moderate
Ntambue et al. (2018) [47] DRC Congo Urban Cross-sectional
hospital-based
Women receiving services in
maternity wards
2014 High
Odhiambo et al. (2019) [48] Rwanda Rural Retrospective Women who delivered by
emergency cesarean section
2015 High





Parmar et al. (2017) [50] Zambia Urban Cross-sectional
hospital-based
Women receiving safe and
unsafe abortions
2013–2014 Moderate
Paul et al. (2015) [51] Sierra Leone Urban and Rural Cross-sectional Women with unsafe
abortion complications
2012 Moderate















Ravit et al. (2015) [54] Mali Unspecified Case-control Women who underwent
Caesarean section
2008–2011 Moderate





Sambo et al. (2013) [56] Nigeria Rural Cross-sectional
household survey
Pregnant women and those
who delivered recently
(within 6 weeks postpartum)
2011 High
Sicuri et al. (2011) [57] Mozambique Rural Cross-sectional
hospital-based
Low birth weight babies 2007 High
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reported both direct and indirect costs. The health
system costs for eclampsia (n = 2) range from USD
122.7–186.4 and no capital cost was measured. For
care of low-birth weight babies, the patient cost
(n = 3) ranged between USD 38.2–486.7, and two
studies contained both direct and indirect costs,
while only one study by Sicuri et al. (2011) from
Mozambique reported an average health system cost
of about USD 514 for caring such babies. For the
management of maternal hemorrhage, patient cost
(n = 4) ranges between USD 65.1–196.2, and half of
the studies reported both direct and indirect costs.
The health system cost for maternal hemorrhage
range between USD 30.3–127.4 and all the studies
reported recurrent health system cost only.
Figures 3 and 4 compare whether out of pocket
health expenditures for normal delivery, C-section,
eclampsia, and maternal hemorrhage was higher
than 10% of the average gross national income per
capita for different countries in sub-Saharan Africa.
Out of pocket cost for normal delivery services was
catastrophic for only one study from DR Congo
Table 2 Study characteristics (Continued)




























those with normal delivery
2006–2007 Moderate
Fig. 2 Distribution of studies in sub-Saharan Africa
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Table 3 Costs for normal delivery and Caesarean sections
Authors name Country Data collection year Cost category Base year cost (USD) Cost (USD) in 2018
Normal delivery
Patient perspective
Asante et al. (2007) [19] Ghana 2004 Direct 42.1 52.4
Borghi et al. (2003) [21] Benin 2000 Direct 23.0 33.5
Ghana 1999–2000 Direct 15.0 21.9
Deboutte et al. (2015) [27] DR Congo 2007–2008 Direct 15.3 18.5
Kalu-Umeh et al. (2013) [34] Nigeria 2010 Direct 9.0 10.4
Kowalewski (2002) [35] Tanzania 1997–1998 Direct & indirect 18.5 28.5
Kruk et al. (2008) [36] Tanzania 2007 Direct 6.9 8.6
Levin et al. (2000) [38] Uganda 1998 Direct & indirect 17.0 26.2
Malawi 1998 Direct & indirect 7.8 120
Ghana 1998 Direct & indirect 16.6 25.5
Meda et al. (2019) [44] Burkina Faso 2016 Direct 6.1 6.4
Ntambue et al. (2018) [47] DR Congo 2014 Direct & indirect 45.0 50.2
Pearson et al. (2011) [52] Ethiopia 2008–2009 Direct 14.4 16.8
Tanzania 2006 Direct 4.5 5.6
Burkina Faso 2006 Direct 6.6 8.2
Perkins et al. (2009) [53] Kenya 2006 Direct 14.2 17.7
Ridde et al. (2012) [55] Burkina Faso 2010 Direct 9.9 11.4
Sambo et al. (2013) [56] Nigeria 2013 Direct 9.6 10.7
Provider perspective
Both et al. (2007) [22] Tanzania 2003 Recurrent & capital 6.3 8.6
Dalaba et al. (2013) [24] Ghana 2010 Recurrent & capital 63.2 72.8
Johns et al. (2019) [33] Uganda 2017–2018 Recurrent & capital 41.3 43.2
Zambia 2017–2018 Recurrent & capital 23.0 24.1
Levin at al (2000) [38] Uganda 1998 Recurrent 21.2 32.7
Malawi 1998 Recurrent 14.3 22.0
Ghana 1998 Recurrent 10.8 16.7
Orach et al. (2007) [49] Uganda 2003 Recurrent & capital 6.1 8.4
Witter et al. (2010) [63] Senegal 2006–2007 Recurrent 15.0 18.7
C-section
Patient perspective
Arsenault et al. (2013) [18] Mali 2008–2011 Direct 107.0* 119.5
Asante et al. (2007) [19] Ghana 2004 Direct 195.0 242.9
Deboutte et al. (2015) [27] DR Congo 2007–2008 Direct 79.7 96.5
Honda et al. (2011) [30] Madagascar 2007–2008 Direct 139.0 162.1
Kalu-Umeh et al. (2013) [34] Nigeria 2010 Direct 99.0 114.0
Kowalewski [35] Tanzania 1997–1998 Direct & indirect 135.0 208.0
Levin et al. (2000) [38] Uganda 1998 Direct & indirect 36.2 55.8
Ghana 1998 Direct & indirect 104.0 160.2
Meda et al. (2019) [44] Burkina Faso 2016 Direct 136.4 142.7
Ntambue et al. (2018) [47] DR Congo 2014 Direct & indirect 338.0 377.3
Pearson et al. (2011) [52] Ethiopia 2008–2009 Direct 51.1 59.6
Ravit et al. (2015) [54] Mali 2008–2011 Direct 163.0 182.0
Mori et al. Health Economics Review           (2020) 10:26 Page 8 of 15
[47], however, costs were catastrophic in eight stud-
ies out of the twelve [18, 19, 27, 30, 35, 44, 47, 54]
that reported delivery by the C-section. Out of
pocket payments were also catastrophic in three out
of six studies on the management of eclampsia [21,
47, 54], one out of four studies about abortion ser-
vices [31], one out of three studies on the manage-
ment of low birth weight babies [59] and four out
of five studies on the management of hemorrhage
[21, 44, 47, 54]. None of the studies on PAC costs
indicated that catastrophic health expenditures were
incurred.
Discussion
This review shows that pregnancy and childbearing
expose women and their families to a lot of out-of-
pocket (OOP) payments, particularly in the presence
of complications. For normal spontaneous vaginal de-
liveries, women pay between USD 5.6–52.4 and for
C-section they pay between USD 55.8–377.3, meaning
on average it costs seven times more to deliver by C-
section. The OOP payments usually constitute costs
of drugs and medical supplies like cotton wools, sy-
ringes, transportation to and from the health facilities,
food, drinks and unofficial payments to health
workers. Mean OOP payments were either very close
to or exceeded 10 % of an average national per capita
income for some countries, thus most likely exposing
patients and their families to substantial financial
burden.
Results from the included studies show that cata-
strophic health expenditures were common among the
study participants [16–18, 27, 30, 31, 59]. In Bunia DR
Congo, the user cost of C-section was estimated at 79.7
USD, which was slightly above the monthly family
income of 75.5 USD [27]. In Birnin-Kebbi Nigeria, aver-
age monthly family income was 18.8 USD compared to
the average cost of care for emergency obstetric care
(EmOC) of about 246 USD [16]. In rural Ethiopia, more
than two-thirds of the studied families experienced cata-
strophic health expenditure for maternal healthcare [17].
In Mali, between 20 and 54% of the studies house-
holds incurred catastrophic health expenditure on
EmOC [18]. In Burkina Faso, 12% of women with
abortion experienced catastrophic health expenditure
[31]. In Madagascar, the proportion of OOP for C-
section among the richest and the poor was 33% and
109%, respectively [30].
Our study indicates that pregnancy and childbearing
complications are also relatively expensive to the
healthcare systems in sub-Saharan Africa. Health sys-
tems use between USD 8–73 per patient for normal
deliveries, but a staggering USD 80–562 for C-
section, USD 40–300 for medical abortion, USD 40–
150 for post-abortion care, USD 120–190 to care for
eclampsia, USD 30–130 to treat hemorrhage and
about USD 500 to care for low-birth weight babies.
In 2009 it was estimated that the annual cost to treat
unsafe abortion complications in sub-Saharan Africa
ranged from USD 68–76 million [64] and in 2014, it
was estimated that the cost required to provide post-
abortion care in developing countries was USD 232
million [65]. A large chunk of these costs could be
prevented by investing in modern contraceptive use
to prevent unwanted pregnancies, legalizing abortion
where it is illegal and implementing policies with the
potential to reduce adolescent pregnancies. High costs
that are associated with access to healthcare hinder
the utilization of maternal health services in resource-
poor settings [66, 67].
Table 3 Costs for normal delivery and Caesarean sections (Continued)
Authors name Country Data collection year Cost category Base year cost (USD) Cost (USD) in 2018
Provider perspective
Both et al. (2007) [22] Tanzania 2003 Recurrent & capital 69.3 94.5
Cornelissen et al. (2017) [23] Malawi 2014–2015 Recurrent & capital 351.0 391.8
Deboutte et al. (2013) [26] DR Congo 2007–2008 Recurrent & capital 157.8 184.0
Johns et al. (2019) [33] Uganda 2017–2018 Recurrent & capital 238.5 249.5
Zambia 2017–2018 Recurrent & capital 537 561.8
Levin et al. (2000) [38] Uganda 1998 Recurrent 79.8 122.9
Malawi 1998 Recurrent 81.9 126.1
Ghana 1998 Recurrent 72.2 111.2
Lofgren et al. (2015) [43] Uganda 2011 Recurrent & capital 71.4 79.7
Odhiambo et al. (2019) [48] Rwanda 2015 Recurrent & capital 339 359.2
Orach et al. (2007) [49] Uganda 2003 Recurrent & capital 58.7 80.1
Witter et al. (2010) [63] Senegal 2006–2007 Recurrent 137.0 165.9
*represents costs of treatment only
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This study has several limitations, which requires
care in its interpretation. Firstly, the included studies
were methodologically very heterogeneous in terms of
range patient and health system costs included mak-
ing it hard to fully disaggregate the costs. Secondly,
costs are very context-specific especially for non-
traded goods and services such as wages and salaries,
which are usually one of the main cost drivers. Thus,
in countries where salaries and prices of commodities
are high always tend to skew the average costs. Also,
Table 4 Costs for abortion and PAC
Authors name Country Data collection year Cost category Base cost (USD) Cost (USD) in 2018
Abortion
Patient perspective
Akalu et al. (2012) [17] Ethiopia 2007–2008 Direct 13.4a 15.7
Henshaw et al. (2008) [29] Nigeria 2002–2003 Direct 32.2 43.9
Ilboudo et al. (2015) [31] Burkina Faso 2012 Direct 56.0b 61.3
Burkina Faso 2012 Direct 37.0c 40.5
Lince et al. (2015) [39] South Africa 2010 Direct & indirect 21.2 24.5
Lince et al. (2017) [41, 42] South Africa 2009–2011 Direct & indirect 10.0 11.2
Moore et al. (2018) [46] Zambia 2014–2015 Direct 62.0 65.7
Pearson et al. (2011) [52] Ethiopia 2008–2009 Direct 10.0 11.7
Sundaram et al. (2013) [58] Uganda 2011–2012 Direct 23.0 25.2
Provider perspective
Le et al. (2015) [37] South Africa 2014 Recurrent & capital 281.2 298.3
Lince et al. (2017) [41, 42] South Africa 2011–2013 Recurrent & capital 65.4 70.5
Lince et al. (2018) [40] South Africa 2013–2014 Recurrent & capital 250.3d 265.5
Parmar D [50] Zambia 2013–2014 Recurrent 38.0e 40.3
Post-abortion care
Patient perspective
Henshaw et al. (2008) [29] Nigeria 2002–2003 Direct 116.0 158.4
Ilboudo et al. (2015) [31] Burkina Faso 2012 Direct 33.0b 36.1
Burkina Faso 2012 Direct 19.0c 20.8
Meda et al. (2019) [44] Burkina Faso 2016 Direct 32.1 33.6
Moore et al. (2018) [46] Zambia 2014–2015 Direct 81.0 85.8
Sundaram et al. (2013) [58] Uganda 2011–2012 Direct 26.0 28.4
Provider perspective
Benson et al. (2015) [20] Malawi 2010 Recurrent 40.0 46.1
Levin et al. (2000) [38] Uganda 1998 Recurrent 46.5 71.7
Malawi 1998 Recurrent 35.9 55.2
Ghana 1998 Recurrent 65.2 100.4
MoH –Kenya (2018) [45] Kenya 2016 Recurrent 58.0 60.7
Parmar et al. (2017) [50] Zambia 2013–2014 Recurrent 52.0 55.2
Paul et al. (2015) [51] Sierra Leone 2012 Recurrent 68.0 74.4
Vlassoff et al. (2014) [61] Rwanda 2012 Recurrent & capital 93.0 101.7
Vlassoff et al. (2012) [60] Uganda 2010 Recurrent & capital 131.2 151.1
Vlassoff et al. (2009) [64] Ethiopia 2008 Recurrent & capital 100.0 116.6
aaverage of costs in public facilities (USD 16.12) and private USD 10.73
bprocedure for induced abortion
ccost of care for spontaneous abortion
daverage for dilatation & evacuation with misoprostol (88.90 USD), medical induction with mifepristone+misoprostol (298.03 USD) and medical induction with
misoprostol only (364.08 USD)
e Costs of unsafe abortion
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there could be a lot of variations in the structure and
complexity of the healthcare system and services
available for managing pregnancy and birth-related
complications between countries, hence resource re-
quirements and costs could infinitely vary from one
place to another. For this reason, we could not aggre-
gate the costs into meaningful means or medians.
Our findings regarding the costs of maternal health
care have several policy implications despite the lim-
itations. First, it is well documented that adolescent
pregnancy and childbearing are associated with ele-
vated risks of complications [68, 69], which are
mainly concentrated in sub-Saharan Africa [70]. Our
study enhances the understanding of the financial
implications of these complications both for patients,
families, and health systems. Policies that can delay
teen pregnancies, therefore, have the potential not
only to reduce maternal morbidity and mortality but
also to save patients and health systems a significant
amount of healthcare resources. Second, this review
shows that maternal complications may result in
OOP expenditures that are largely catastrophic espe-
cially among the poorest households. New innovative
strategies are urgently needed to protect women and
Table 5 Costs of other complications
Authors name Country Data collection year Cost category Base cost (USD) Cost (USD) in 2018
Eclampsia
Patient perspective
Borghi et al. (2003) [21] Benin 2000 Direct 119.0 173.5
Ghana 1999–2000 Direct 69.0 100.6
Dalaba et al. (2015) [25] Ghana 2014 Direct & indirect 58.3 61.9
Meda et al. (2019) [44] Burkina Faso 2016 Direct 49.3 51.6
Ntambue et al. (2018) [47] DR Congo 2014 Direct & indirect 206.5b 230.5
Ravit et al. (2015) [54] Mali 2008–2011 Direct 179.8 200.7
Provider perspective
Levin et al. (2000) [38] Uganda 1998 Recurrent 121.015 186.4
Malawi 1998 Recurrent 79.62 122.7
Low birth weight babiesa
Patient perspective
Enweronu et al. (2018) [28] Ghana 2016 Direct & indirect 147.6 154.4
Sicuri et al. (2011) [57] Mozambique 2007 Direct & indirect 31.5 38.2
Tongo et al. (2008) [59] Nigeria 2008 Direct 417.3 486.7
Provider perspective
Sicuri et al. (2011) [57] Mozambique 2007 Recurrent & capital 424.6 514.2
Hemorrhage
Patient perspective
Borghi et al. (2003) [21] Benin 2000 Direct 104.0 151.7
Ghana 1999–2000 Direct 79.0 115.2
Dalaba et al. (2015) [25] Ghana 2014 Direct & indirect 6.84 7.3
Meda et al. (2019) [44] Burkina Faso 2016 Direct 58.35 65.2
Ntambue et al. (2018) [47] DR Congo 2014 Direct & indirect 187.5b 196.17
Ravit et al. (2015) [54] Mali 2008–2011 Direct 140.34 156.67
Provider perspective
Ilboudo et al. (2016) [32] Burkina Faso 2010 Recurrent 26.3 30.3
Levin et al. (2000) [38] Uganda 1998 Recurrent 82.7 127.4
Malawi 1998 Recurrent 74.3 114.5
Ghana 1998 Recurrent 65.3 100.5
aCosts from delivery to discharge from hospital
bAverage cost for vaginal and c-section
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their families from impoverishing OOP, otherwise,
the real impact of abolishing user fees for maternal
services will be hard to be realized.
Conclusion
This is the first systematic literature review to com-
pile comprehensive up-to-date patient and health
system costs of managing pregnancy and birth-
related complications in sub-Saharan Africa. It indi-
cates that these costs are relatively high. It further
shows that patient costs were largely catastrophic
relative to a 10 % of average national per capita in-
come, thus exposing families to immense financial
burden and impoverishment, in particularly poor
Fig. 3 Out of pocket cost versus 10% of per capita income for normal vaginal delivery and C-section
Fig. 4 Out of pocket cost versus 10% of per capita income for specific birth complications
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families that live under one USD per day. Hence
health policies that advocate for free maternal health
services and universal health coverage on maternal
and newborn care should be encouraged and priori-
tized on both national, regional, and international
agenda. Otherwise, the high costs will continue to
hinder access to maternal health services in sub-
Saharan Africa, thus negating the efforts to reduce
infant and maternal mortality rates which are rela-
tively high in this region. Although the study found
a relatively large number of studies, the evidence
base on the costs of maternal care is nevertheless
still scarce; hence, more studies are needed to fill
the gaps.
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